Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.
Ghobrial IM, Xie W, Padmanabhan S, Badros A, Rourke M, Leduc R, Chuma S, Kunsman J, Warren D, Poon T, Harris B, Sam A, Anderson KC, Richardson PG, Treon SP, Weller E, Matous J.
Ghobrial IM, et al. Among authors: treon sp.
Am J Hematol. 2010 Sep;85(9):670-4. doi: 10.1002/ajh.21788.
Am J Hematol. 2010.
PMID: 20652865
Free article.
Clinical Trial.